Opinions
Jerome Hass
RepliCel Life Sciences
RP-X
BUY
Oct 21, 2014
$0.440
Stock price when the opinion was issued
Consumer Products
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
Advertising
Life sciences. Have an interesting regenerative technology. For example, they can take a hair follicle and extract certain cells, and then replicate them 1 million times and then re-inject them back in areas where they are needed. It is very, very rare to have a company this small with 2 products in phase 2 trials. Feels phase 2 is when life science companies add the most value. Next year they will have a 3rd, which is very rare for a company. Thinks they will put the company up for sale next year, and it will become a bidding war.